AMLX
Price
$6.50
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
564.26M
38 days until earnings call
SGMO
Price
$0.56
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
132.74M
43 days until earnings call
Interact to see
Advertisement

AMLX vs SGMO

Header iconAMLX vs SGMO Comparison
Open Charts AMLX vs SGMOBanner chart's image
Amylyx Pharmaceuticals
Price$6.50
Change-$0.00 (-0.00%)
Volume$1.44K
Capitalization564.26M
Sangamo Therapeutics
Price$0.56
Change-$0.00 (-0.00%)
Volume$84.06K
Capitalization132.74M
AMLX vs SGMO Comparison Chart in %
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. SGMO commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Buy and SGMO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (AMLX: $6.50 vs. SGMO: $0.56)
Brand notoriety: AMLX and SGMO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 0% vs. SGMO: 2%
Market capitalization -- AMLX: $564.26M vs. SGMO: $132.74M
AMLX [@Biotechnology] is valued at $564.26M. SGMO’s [@Biotechnology] market capitalization is $132.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileSGMO’s FA Score has 0 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • SGMO’s FA Score: 0 green, 5 red.
According to our system of comparison, AMLX is a better buy in the long-term than SGMO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 4 TA indicator(s) are bullish while SGMO’s TA Score has 3 bullish TA indicator(s).

  • AMLX’s TA Score: 4 bullish, 4 bearish.
  • SGMO’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, AMLX is a better buy in the short-term than SGMO.

Price Growth

AMLX (@Biotechnology) experienced а +28.84% price change this week, while SGMO (@Biotechnology) price change was +13.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

AMLX is expected to report earnings on Aug 07, 2025.

SGMO is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($564M) has a higher market cap than SGMO($133M). AMLX YTD gains are higher at: 71.958 vs. SGMO (-45.363). SGMO has higher annual earnings (EBITDA): -72.14M vs. AMLX (-206.81M). AMLX has more cash in the bank: 204M vs. SGMO (25.2M). AMLX has less debt than SGMO: AMLX (1.38M) vs SGMO (24.9M). SGMO has higher revenues than AMLX: SGMO (63.8M) vs AMLX (-1.27M).
AMLXSGMOAMLX / SGMO
Capitalization564M133M424%
EBITDA-206.81M-72.14M287%
Gain YTD71.958-45.363-159%
P/E Ratio2.81N/A-
Revenue-1.27M63.8M-2%
Total Cash204M25.2M810%
Total Debt1.38M24.9M6%
FUNDAMENTALS RATINGS
SGMO: Fundamental Ratings
SGMO
OUTLOOK RATING
1..100
38
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXSGMO
RSI
ODDS (%)
Bearish Trend 4 days ago
86%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
76%
MACD
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
77%
Advances
ODDS (%)
Bullish Trend 21 days ago
76%
Bullish Trend 20 days ago
74%
Declines
ODDS (%)
Bearish Trend 11 days ago
82%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
88%
Aroon
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRMLF47.930.37
+0.78%
Tourmaline Oil Corp.
CYBQY0.98N/A
N/A
Cyberdyne Inc.
IVREF0.72N/A
N/A
Inovalis Real Estate Investment Trust
NSFMF11.50N/A
N/A
NISSHIN SEIFUN GROUP INC
HAFG0.51-0.24
-31.99%
Holistic Asset Finance Group Co., Ltd.

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been loosely correlated with GRI. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if AMLX jumps, then GRI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
N/A
GRI - AMLX
57%
Loosely correlated
-0.78%
SLRX - AMLX
54%
Loosely correlated
-0.01%
RGNX - AMLX
45%
Loosely correlated
-4.11%
DNLI - AMLX
45%
Loosely correlated
-2.69%
OCUL - AMLX
44%
Loosely correlated
-2.54%
More